The largest database of trusted experimental protocols

Tubastatin alexa647 tracer

Manufactured by Thermo Fisher Scientific

Tubastatin‐Alexa647‐Tracer is a fluorescent dye-labeled compound used for the detection and analysis of target proteins in biological samples. It is designed to specifically bind to and label target proteins, enabling their visualization and quantification through fluorescence-based techniques such as Western blotting, immunocytochemistry, or flow cytometry.

Automatically generated - may contain errors

2 protocols using tubastatin alexa647 tracer

1

HDAC10 Inhibition Assay via TR-FRET

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FRET‐assay was performed in white 384‐well ProxiPlates (PerkinElmer). Reagents were diluted in assay buffer (50 mM HEPES pH 8.0, 150 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 0.01 % Brij‐35). Final assay volume (10 μL) contains 3 nM GST‐HDAC10 (Life Technologies), 30 nM Tubastatin‐Alexa647‐Tracer,[32] and 0.5 nM LanthaScreen Eu‐anti‐GST (Life Technologies). Compound stocks (10 mM DMSO) were diluted in assay buffer. An 11‐fold 1 : 3‐serial dilution of test compounds (1 μL) were presented in the plate and complemented by 9 μL of assay mix. After incubation (1 h, room temperature) TR‐FRET was measured with EnVision plate reader (Ex: 3 flashes of the TRF‐europiumlaser; Em: 620 and 665 nm (665/620 nm ratio). Inhibition was calculated by using negative control (2 % DMSO) and positive control (20 μM vorinostat). Dose‐response curves were fitted in ActivityBase (IDBS) using a four‐parameter logistic model and IC50‐values were calculated.[32]
+ Open protocol
+ Expand
2

HDAC10 Enzyme Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FRET-assay was performed in white 384-well ProxiPlates (PerkinElmer). Reagents were diluted in assay buffer (50 mM HEPES pH 8.0, 150 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35). Final assay volume (10 μL) contains 3 nM GST-HDAC10 (Life Technologies), 30 nM Tubastatin-Alexa647-Tracer[32 (link)], and 0.5 nM LanthaScreen Eu-anti-GST (Life Technologies). Compound stocks (10 mM DMSO) were diluted in assay buffer. An 11-fold 1:3-serial dilution of test compounds (1 μL) were presented in the plate and complemented by 9 μL of assay mix. After incubation (1 h, room temperature) TR-FRET was measured with EnVision plate reader (Ex: 3 flashes of the TRF-europiumlaser; Em: 620 and 665 nm (665/620 nm ratio). Inhibition was calculated by using negative control (2 % DMSO) and positive control (20 μM vorinostat). Dose-response curves were fitted in ActivityBase (IDBS) using a four-parameter logistic model and IC50-values were calculated.[32 (link)]
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!